Eating for Inflammatory Bowel Disease: Assessing the Effect of Dietary Carbohydrates on Gut Microbiota and Implications for Disease Management.
文献摘要
Targeting the gut microbiome through diet remains a priority in the treatment and management of inflammatory bowel diseases (IBD) for patients and clinicians alike. However, expert consensus is lacking, and cross-sectional studies indicate that patients with IBD often adopt low-fiber, high-sugar, and high-protein diets in an effort to control gastrointestinal symptoms and inflammation, with negative implications for gut microbial functions and gastrointestinal inflammation. Although dietary carbohydrates are key modulators of gut microbial composition and function, substantial disagreement persists regarding how carbohydrate digestibility and structural properties influence IBD outcomes. This narrative review summarizes current knowledge on the role of dietary carbohydrates in IBD risk and progression, and critically evaluates recent dietary interventions in which the gut microbiota was included among outcomes to elaborate a potential role of dietary carbohydrates in the clinical management of IBD. We conclude by outlining research priorities needed to affirm a role for dietary carbohydrate modification in the clinical management of IBD and to support the development of practical, evidence-based dietary guidance.